R. Herzog

发表

An investigation of the pharmacokinetics, pharmacodynamics, safety, and tolerability of ciclesonide hydrofluoroalkane nasal aerosol in healthy subjects and subjects with perennial allergic rhinitis.

P. Ratner, R. Nave, M. Wingertzahn, 2011, Pulmonary pharmacology & therapeutics.

Steady-State Pharmacokinetics of Roflumilast and Roflumilast N-Oxide in Patients with Mild and Moderate Liver Cirrhosis

R. Hermann, É. Péterfai, C. Mey, 2007, Clinical pharmacokinetics.

A new method for the determination of the bioavailability of thyroid hormone preparations.

T. Trantow, P. Lücker, L. Gegenheimer, 1994, Methods and findings in experimental and clinical pharmacology.

Effect of Steady‐State Enoxacin on Single‐Dose Pharmacokinetics of Roflumilast and Roflumilast N‐Oxide

M. Elmlinger, P. Ruth, M. Hinder, 2011, Journal of clinical pharmacology.

Effect of repeated dose of erythromycin on the pharmacokinetics of roflumilast and roflumilast N-oxide.

M. Elmlinger, R. Hermann, G. Lahu, 2009, International journal of clinical pharmacology and therapeutics.

Single‐Dose Pharmacokinetics of Roflumilast in Children and Adolescents

K. Neville, G. Kearns, S. Szefler, 2008, Journal of clinical pharmacology.

Pharmacokinetics of ciclesonide and desisobutyryl ciclesonide after administration via aqueous nasal spray or hydrofluoroalkane nasal aerosol compared with orally inhaled ciclesonide: an open-label, single-dose, three-period crossover study in healthy volunteers.

R. Nave, M. Wingertzahn, A. Laurent, 2009, Clinical therapeutics.

Sensitive quantification of roflumilast and roflumilast N-oxide in human plasma by LC-MS/MS employing parallel chromatography and electrospray ionisation.

N. Knebel, F. Reutter, K. Zech, 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Effects of rifampicin on the pharmacokinetics of roflumilast and roflumilast N-oxide in healthy subjects.

K. Duffy, R. Hermann, O. von Richter, 2009, British journal of clinical pharmacology.

A pilot study on the determination of the relative bioavailability of levo-thyroxine.

T. Trantow, P. Lücker, H. Fuder, 1995, Methods and findings in experimental and clinical pharmacology.

Pharmacokinetics of teduglutide in subjects with renal impairment

A. Halabi, G. Lahu, M. Hartmann, 2013, European Journal of Clinical Pharmacology.

Effect of Single and Repeated Doses of Ketoconazole on the Pharmacokinetics of Roflumilast and Roflumilast N‐Oxide

R. Hermann, O. Richter, G. Lahu, 2008, Journal of clinical pharmacology.

TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study).

J. Drewe, A. Miserez, B. Müller, 2001, The Journal of clinical endocrinology and metabolism.

Study on the absolute bioavailability of quinine and theophylline from tablets after single dose oral administration as compared to intravenous infusion in healthy male non-smoking volunteers.

P. Lücker, H. Fuder, R. Herzog, 1994, Methods and findings in experimental and clinical pharmacology.

Investigation of a Potential Food Effect on the Pharmacokinetics of Roflumilast, an Oral, Once‐Daily Phosphodiesterase 4 Inhibitor, in Healthy Subjects

R. Hermann, D. Hauschke, T. Bethke, 2006, Journal of clinical pharmacology.

Effect of Fluvoxamine on the Pharmacokinetics of Roflumilast and Roflumilast N-Oxide

R. Hermann, O. Richter, G. Lahu, 2007, Clinical pharmacokinetics.